AMERICAN PUBLIC EDUCATION INC (APEI) stock intrinsic value fair value estimate & owner earnings analysis

American Public Education (APEI) operates three accredited higher-education institutions: American Public University System (APUS), which serves primarily military-affiliated and veteran students online; Rasmussen University (RU), a multi-campus nursing- and healthcare-focused university; and Hondros College of Nursing (HCN). The company also sold a smaller wellness-benefits subsidiary (GSUSA) in 2025. In November 2021 APEI acquired Rasmussen University, roughly doubling revenue but also weighing heavily on results for the next two years: the combined company recorded a $146.9 million non-cash goodwill and intangible impairment in 2022 and a further impairment in 2023, reflecting that it had paid more for Rasmussen than it was initially earning back. Since then, the business has recovered: instructional costs fell from 47.3% to 45.8% of revenue in the most recent year, Rasmussen's enrollment grew 8.7%, and operating margin expanded from 5.3% to 7.3% of revenue. In June 2025 the company also fully redeemed the preferred stock it had issued to help fund the acquisition, removing a roughly $6 million-a-year dividend claim that had stood ahead of common shareholders. We valued the company on owner earnings - operating cash flow adjusted to remove stock compensation, the swings from working-capital timing, and only the capital spending needed to maintain (rather than grow) the business. Because non-cash impairment charges do not touch this figure, we accounted for them in our judgment about the growth story rather than in the earnings level. We treated 2022, the first and most disrupted year of the merger, as a one-off transition year and anchored current earning power on the three most recent years (2023-2025), putting normalized owner earnings at roughly $1.15 per share today, with the most recent year running well above that as the recovery has taken hold. Base case: we expect the margin recovery and Rasmussen's enrollment growth to continue for a few more years before settling into slower, single-digit growth, as cost discipline continues and Rasmussen/Hondros scale toward APUS's higher margins. On this path we estimate the shares are worth about $43. Bear case: American Public University's federal-aid ratio - the share of its revenue coming from military tuition assistance, VA benefits, and other federal student aid - was 89% in 2025, just under the 90% regulatory ceiling; a school that stays above that ceiling for two consecutive years loses access to federal student aid entirely, a severe risk for a business this concentrated in military-affiliated students. If the company has to actively slow enrollment growth to stay under that ceiling, or a further government-shutdown-style disruption (as occurred in the fourth quarter of 2025) again dents tuition-assistance funding, earnings would likely stagnate near today's level for years rather than grow. We also weighed in the roughly $95 million of debt on the balance sheet, which carries minimum-cash and interest-coverage requirements, and the company's history of overpaying for its one large acquisition. On this path we estimate the shares are worth about $18.50. Bull case: if Rasmussen and Hondros keep converging toward APUS's already-higher profitability and the company successfully manages its federal-aid concentration (management has flagged this as an active area of focus, with several levers available, including growing non-federal-aid enrollment), earnings could keep compounding at a high-single to low-double-digit rate through most of the next decade. On this path we estimate the shares are worth about $53. Beyond the next ten years we assume earnings power holds roughly steady rather than continuing to grow. The multi-decade relationship between American Public University and U.S. military tuition-assistance and VA benefit programs, combined with its low-cost online delivery model, is real and durable, but we did not find a specific reason to expect the earnings base to keep expanding past what is already captured in the ten-year outlook. Given the binary nature of the federal-aid concentration risk, the margin-of-safety price carries a meaningful discount to our base-case estimate, and the business trigger is the company's federal-aid ratio confirmed safely under 90% for a full additional fiscal year. One item we could not fully reconcile from the filings: the FY2024 annual report showed a $26.5 million intangible-asset impairment for 2024, but the following year's annual report restated that figure to zero. We used the later, restated figure, consistent with treating the most recent restatement as authoritative, but note the discrepancy here for transparency.